학술논문
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response.
Document Type
Academic Journal
Author
Campopiano MC; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Ghirri A; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Prete A; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Lorusso L; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Puleo L; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Cappagli V; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Agate L; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Bottici V; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Brogioni S; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Gambale C; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Minaldi E; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Matrone A; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Elisei R; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Molinaro E; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Source
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Subject
Language
English
ISSN
1664-2392
Abstract
Currently, the differentiated thyroid cancer (DTC) management is shifted toward a tailored approach based on the estimated risks of recurrence and disease-specific mortality. While the current recommendations on the management of metastatic and progressive DTC are clear and unambiguous, the management of slowly progressive or indeterminate disease varies according to different centers and different physicians. In this context, active surveillance (AS) becomes the main tool for clinicians, allowing them to plan a personalized therapeutic strategy, based on the risk of an unfavorable prognosis, and to avoid unnecessary treatment. This review analyzes the main possible scenarios in treated DTC patients who could take advantage of AS.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2023 Campopiano, Ghirri, Prete, Lorusso, Puleo, Cappagli, Agate, Bottici, Brogioni, Gambale, Minaldi, Matrone, Elisei and Molinaro.)
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2023 Campopiano, Ghirri, Prete, Lorusso, Puleo, Cappagli, Agate, Bottici, Brogioni, Gambale, Minaldi, Matrone, Elisei and Molinaro.)